BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

387 related articles for article (PubMed ID: 29339210)

  • 1. The NLRP3 inflammasome: Role in metabolic disorders and regulation by metabolic pathways.
    Jiang D; Chen S; Sun R; Zhang X; Wang D
    Cancer Lett; 2018 Apr; 419():8-19. PubMed ID: 29339210
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic Targeting of NLRP3 Inflammasomes by Natural Products and Pharmaceuticals: A Novel Mechanistic Approach for Inflammatory Diseases.
    Jahan S; Kumar D; Chaturvedi S; Rashid M; Wahajuddin M; Khan YA; Goyal SN; Patil CR; Mohanraj R; Subramanya S; Ojha S
    Curr Med Chem; 2017; 24(16):1645-1670. PubMed ID: 28245768
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hydrogen-Rich Saline Attenuated Subarachnoid Hemorrhage-Induced Early Brain Injury in Rats by Suppressing Inflammatory Response: Possible Involvement of NF-κB Pathway and NLRP3 Inflammasome.
    Shao A; Wu H; Hong Y; Tu S; Sun X; Wu Q; Zhao Q; Zhang J; Sheng J
    Mol Neurobiol; 2016 Jul; 53(5):3462-3476. PubMed ID: 26091790
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolic regulation of NLRP3.
    Hughes MM; O'Neill LAJ
    Immunol Rev; 2018 Jan; 281(1):88-98. PubMed ID: 29247992
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mitochondria, the NLRP3 Inflammasome, and Sirtuins in Type 2 Diabetes: New Therapeutic Targets.
    Rovira-Llopis S; Apostolova N; Bañuls C; Muntané J; Rocha M; Victor VM
    Antioxid Redox Signal; 2018 Sep; 29(8):749-791. PubMed ID: 29256638
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mitophagy: a balance regulator of NLRP3 inflammasome activation.
    Kim MJ; Yoon JH; Ryu JH
    BMB Rep; 2016 Oct; 49(10):529-535. PubMed ID: 27439607
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of NLRP3 inflammasome in the pathogenesis of cardiovascular diseases.
    Liu D; Zeng X; Li X; Mehta JL; Wang X
    Basic Res Cardiol; 2018 Jan; 113(1):5. PubMed ID: 29224086
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NLRP3 Inflammasome Activation in Adipose Tissues and Its Implications on Metabolic Diseases.
    Wu KK; Cheung SW; Cheng KK
    Int J Mol Sci; 2020 Jun; 21(11):. PubMed ID: 32545355
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolic injury-induced NLRP3 inflammasome activation dampens phospholipid degradation.
    Rampanelli E; Orsó E; Ochodnicky P; Liebisch G; Bakker PJ; Claessen N; Butter LM; van den Bergh Weerman MA; Florquin S; Schmitz G; Leemans JC
    Sci Rep; 2017 Jun; 7(1):2861. PubMed ID: 28588189
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vascular endothelial cells senescence is associated with NOD-like receptor family pyrin domain-containing 3 (NLRP3) inflammasome activation via reactive oxygen species (ROS)/thioredoxin-interacting protein (TXNIP) pathway.
    Yin Y; Zhou Z; Liu W; Chang Q; Sun G; Dai Y
    Int J Biochem Cell Biol; 2017 Mar; 84():22-34. PubMed ID: 28064010
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Negative regulators and their mechanisms in NLRP3 inflammasome activation and signaling.
    Kim JK; Jin HS; Suh HW; Jo EK
    Immunol Cell Biol; 2017 Aug; 95(7):584-592. PubMed ID: 28356568
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation and Function of the Nucleotide Binding Domain Leucine-Rich Repeat-Containing Receptor, Pyrin Domain-Containing-3 Inflammasome in Lung Disease.
    Lee S; Suh GY; Ryter SW; Choi AM
    Am J Respir Cell Mol Biol; 2016 Feb; 54(2):151-60. PubMed ID: 26418144
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stressing out the mitochondria: Mechanistic insights into NLRP3 inflammasome activation.
    Yabal M; Calleja DJ; Simpson DS; Lawlor KE
    J Leukoc Biol; 2019 Feb; 105(2):377-399. PubMed ID: 30589456
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The NLRP3 inflammasome contributes to host protection during Sporothrix schenckii infection.
    Gonçalves AC; Ferreira LS; Manente FA; de Faria CMQG; Polesi MC; de Andrade CR; Zamboni DS; Carlos IZ
    Immunology; 2017 Jun; 151(2):154-166. PubMed ID: 28140444
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modulatory Mechanisms of the NLRP3 Inflammasomes in Diabetes.
    Ding S; Xu S; Ma Y; Liu G; Jang H; Fang J
    Biomolecules; 2019 Dec; 9(12):. PubMed ID: 31835423
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Muramyl dipeptide activates human beta defensin 2 and pro-inflammatory mediators through Toll-like receptors and NLRP3 inflammasomes in human dental pulp cells.
    Lee SI; Kang SK; Jung HJ; Chun YH; Kwon YD; Kim EC
    Clin Oral Investig; 2015 Jul; 19(6):1419-28. PubMed ID: 25467233
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Posttranslational Regulation of the NLR Family Pyrin Domain-Containing 3 Inflammasome.
    Shim DW; Lee KH
    Front Immunol; 2018; 9():1054. PubMed ID: 29868015
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inflammasomes on the Crossroads of Innate Immune Recognition and Metabolic Control.
    Próchnicki T; Latz E
    Cell Metab; 2017 Jul; 26(1):71-93. PubMed ID: 28683296
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phytochemicals as Novel Therapeutic Strategies for NLRP3 Inflammasome-Related Neurological, Metabolic, and Inflammatory Diseases.
    Pellegrini C; Fornai M; Antonioli L; Blandizzi C; Calderone V
    Int J Mol Sci; 2019 Jun; 20(12):. PubMed ID: 31200447
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulatory Mechanisms of the NLRP3 Inflammasome, a Novel Immune-Inflammatory Marker in Cardiovascular Diseases.
    An N; Gao Y; Si Z; Zhang H; Wang L; Tian C; Yuan M; Yang X; Li X; Shang H; Xiong X; Xing Y
    Front Immunol; 2019; 10():1592. PubMed ID: 31354731
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.